NewAmsterdam Pharma (NAMS) Exchange Rate Effect (2023 - 2026)

NewAmsterdam Pharma has reported Exchange Rate Effect for 4 years, with the latest figure at -$1.3 million in Q1 2026.

• Quarterly Exchange Rate Effect fell 135.32% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (up 1531.03% YoY) and the FY2025 annual result came in at $12.8 million, up 287.58% from the prior year.
• Exchange Rate Effect slipped to -$1.3 million in Q1 2026 per NAMS's latest filing, from -$60000.0 in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $8.8 million in Q2 2025 and troughed at -$7.9 million in Q4 2024.
• A 4-year average of $744384.6 and a median of -$60000.0 in 2025 frame the typical range for Exchange Rate Effect.
• The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect tumbled 252.05% in 2024, then surged 1070.96% in 2025.
• Over 4 years, Exchange Rate Effect stood at $5.2 million in 2023, then sank by 252.05% to -$7.9 million in 2024, then soared by 99.24% to -$60000.0 in 2025, then sank by 2120.0% to -$1.3 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.3 million, -$60000.0, and $222000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.